메뉴 건너뛰기




Volumn 25, Issue 2, 2003, Pages 142-144

Provoked bradycardia after paroxetine administration [5]

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CAPTOPRIL; CARVEDILOL; MIRTAZAPINE; PAROXETINE;

EID: 0037348275     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(02)00274-8     Document Type: Letter
Times cited : (3)

References (9)
  • 1
    • 0029746451 scopus 로고    scopus 로고
    • Bradycardia after beginning therapy with metoprolol and paroxetine
    • Konig F., Hafele M., Hauger B., et al. Bradycardia after beginning therapy with metoprolol and paroxetine. Psychiatr Prax. 23:1996;244-245.
    • (1996) Psychiatr Prax , vol.23 , pp. 244-245
    • Konig, F.1    Hafele, M.2    Hauger, B.3
  • 2
    • 0032573877 scopus 로고    scopus 로고
    • Comparison of paroxetine, and nortriptyline in depressed patients with ischemic heart disease
    • Roose S.P., Laghrissi-Thode F., Kennedy J.S., et al. Comparison of paroxetine, and nortriptyline in depressed patients with ischemic heart disease. JAMA. 279:1998;287-291.
    • (1998) JAMA , vol.279 , pp. 287-291
    • Roose, S.P.1    Laghrissi-Thode, F.2    Kennedy, J.S.3
  • 3
    • 0034077924 scopus 로고    scopus 로고
    • Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder
    • Yeragani V.K., Pohl R., Jampala V.C., et al. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety. 11:2000;126-130.
    • (2000) Depress Anxiety , vol.11 , pp. 126-130
    • Yeragani, V.K.1    Pohl, R.2    Jampala, V.C.3
  • 4
    • 0008803827 scopus 로고    scopus 로고
    • Paroxetine affects metoprolol pharmacokinetics, and pharmacodynamics in healthy volunteers
    • Hemeryck A., Lefebvre R.A., De Vriendt C., Belpaire F.M. Paroxetine affects metoprolol pharmacokinetics, and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther. 67:2000;283-291.
    • (2000) Clin Pharmacol Ther , vol.67 , pp. 283-291
    • Hemeryck, A.1    Lefebvre, R.A.2    De Vriendt, C.3    Belpaire, F.M.4
  • 5
    • 0034749793 scopus 로고    scopus 로고
    • Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients
    • Graff D.W., Williamson K.M., Pieper J.A., et al. Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients. J Clin Pharmacol. 41:2001;97-106.
    • (2001) J Clin Pharmacol , vol.41 , pp. 97-106
    • Graff, D.W.1    Williamson, K.M.2    Pieper, J.A.3
  • 6
    • 0028271342 scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of carvedilol
    • Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet. 26:1994;335-346.
    • (1994) Clin Pharmacokinet , vol.26 , pp. 335-346
    • Morgan, T.1
  • 7
  • 8
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity, and mortality in patients with chronic heart failure
    • Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity, and mortality in patients with chronic heart failure. U S Carvedilol Heart Failure Study Group N Engl J Med. 334:1996;1349-1355.
    • (1996) U S Carvedilol Heart Failure Study Group N Engl J Med , vol.334 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.